y[F8?B4NbM4zܤ ـHl˒-[Wf43{ZcKϙ3g?~[[olIox Gҹ7 JK#kA*}|NbR?ӷ:pN[{1Li8d7p84Ȥ7z0eR0}ڗ RU?e_ợYORWIGp,]ŧ=u_Kา Ůe&$C/,`2 `*y4{+2 ҄lvw6jy2fx8^7y!i=0ܹ̕^ ¶TZY7Ak h<^z+w_?^VXo.u^/a_㧶wOV{2<?Ji>|<:- qV߻=~_OO@8j6of oΏ[tsڌQXAO=|Rx 'vu$7<=f[Rwxg) j؏N]ݝVп޿ 3?X]C_ղSۋmPظxC:_z!=ň4㛃8ŽrLJiXxY{YϷ.*w<9;oբ .6'CR#;Yءʉoau#e$V>Q Z[p!â@1`-hD:nau\ D n|ZM듏w xxsy6Ygr03yyaY@l~;K8Į'<9t݉;>8q#r*idYSon[sY|ۯookJ/K:/緧wwe}>|Uϯo?wwO7ѷHNRzmݮkպQ?-NחKInmnZa΁t>#c+:N^}p<IbK9Ã!>nvӕ49~^V#XxSګ7Q (9l9 ^F?NOn.Iqr//N M#MJ?g_WwNj98L^c7|f=gv 6 , F N)_-uD;:h]#o@ !; p]c 5A?<څr`A|-熛h`ɒe ƒaހ+ q )H`D`dD&;v\<#4 H=MdzH>={/ܽחãgqis =_RE Y{9 w^?@\+dҥjLRYODZ>9j=p!J!v7TSUL8rm=> rI[޽KT!c7CQ h}{}|}3CP5'4.O>vՇ[c[|x<Ά 6q<8ه>+h^qxF._q>fYqn\y<ΏK5ݣcYmAp|_nq3lz>|ؽ9no>_p[1{N'^ISqtx|ub6=w}֌ڛv({.| ޮ?^ .S ybOg!8j$xy?|ңNTJQRoS)w1:0ß9=BhM:kקt~ Ὀ9qOZ6yUZP) g˃3D5a}윞^b+[.(=WrJYVݽvO.eD%v/O?~K}|[P2:>NC"͜(z#k vgIyy ?Fs~]|)tsI?&o[sGn+O@? $N+|QkUߕоK 1>{9`¢d5v8 /C9H4?BfӃ]4 gߜC"=}O$|ir(࿿.\ްYJ/*G -?b Zqf1z\`zȻbq[=`ϏObέuΫޜȄ1#77BsNB‰J Q:(( ]^!{r, { 9LT :z~V? )N>% 1 LPT8#$yhkb[:ֱ˝ֽCtx`M`~,tUcӀ7# F⟀I9FK/1:m.D(x$A`bs|szNeh@F%vstǭ#x#Lt0fzq"B1KQb 36~ a}c| crEQ%E¦ph7x]߯M'EC@& 0j&iD ?&CtP rgZKpC)D+ɜ=QR*)VZYE7h@9Rk2*u*@ix $P#7RBzzXixE(`N2s3>(oC'e\cD 0AwCΉjW- ]|7!Dٺ9=mgmyOi];y ldh)/]0UWy mk5?QzDAx_{y<]! c pИV~ [LRX,.ay K`}Z 0s^`/R?|ߨ׻+ߍg7¯v AK-8f7~r!8K9gEHFTtMYmz"$T)#@w|CtS4?]7j"" .|azc/֟-j}2m/Ѕ<]DT&z>weM$7B |swvXy%wxWp!|>@VwP5'Y[|u wΟ[ Cz7j.߇7x px0K~l;}-rXuq] V~lXSdi M睥?nę 6/s2x nB| P?S} 0ZR~;߁zv\~EHDSgHSH1FWB !|MDr]@@*{!R}뿸kl}L ??}?F:^4KNub^>2 9\7t{_FFiq gՓqQ@*ӜnD EOYx~<1’F8MNcbTVE$nYPZ6psrTTM$/!CvI稵%bOo{W`[라i?uj$pŠxz<N>_×K=wq|7%>S^ ށfo<̠P@Yūa=V! "@Dӏ%n yͬ8..޷|q=~|H[nN7ۓQ;&[\g4٢.mh|[t9 GUFPӄ "r#)Lp̌C->^Βף 4ZnV1H[=! Yy (j V L4H PGnOě&/0P񁣼Hʂx#c)2khaA異rC#̂}%$c3ER",*%պ? /5)T<,@Yca.&f ɝ; ]HA{+ K!Z$mD8;F%V|~ brޖ*#x\ѻxZ|eH>0<c>=rU R>R"ܟ+.N7[ )QPS7,1as3YH ( h}g^y+uf#߽|(`]NߨVEQUZC,y@a3Z cM=%YOX;^AoĀ4و0iG?՗!>Dœ\.yi5z/ MJntx§/0:;h+:?&ъ#9#g&S`$>-r,!Cu~7q/Q|6_Idc(s!1626 @u|qE1_,v#~7!>'q1BuN&X fXa*D1N6^xӷ:̼/o{ňva:@S@crAP=HD?,eEn?7Vl_̓Ǜ֋VU}_=b}޺<ɌSUI~h/w[aح&qOd8yh=/.o_F?˻ݗ˧9>W}h=޼? ,ۏv}xݺ\3>S iz{{iK$]\Z߶ə/229hϯ֯J`۾byj|ѾNJRGFg,/v0lyu3~z.'WR=[Ey V0#LikGwyq{틦g[W|c@߾~v;/Z}ww=>h_ g`֝'vf~=/חIB]O wj-m@Q?{Vgj^_܇k3>K⤿L,n\Kً4_?kry/r$\HC ~?g;/wwޟ$rwY=z<ɏg$k~qp.W̓VsuYki|}>UWُ&gS]:KҮ'Vx\Y^|y~.?ݝKG>Lջj63Ny5<=m|9c|qx\ևvYʎяӛcb}sJ|~[W_>~z]~>EzSٸ=?<{?JRvb /v ?toqR?= uן_ /zy}fz/]9.Z?w t}vs/w[7}`* 7ٽۭݡ*ET}qؔ:0ڷq[tᶣ'{}s|1T凶=ggN/avN_Q4},;~s/nVG8mܾoށ#kc^ğoޕuuusøtl|~맯_M]tt]F:ݽqqҷpxɸsQ_^U[_lW `vptypu1\E995Tqھo?:z.xʧsþU4ӣ/F%.yUߞ|?W7l~KG1LMG1Nw/_/I6mo^5{s6jK_Ga}u;/?Y29+y]ݝ5^~ؑ:ymI[~|}nmJNƋpl6.N^ͷ_`_>w^/N^7gۅ_~U ]WeKoge9&.8Ùڼ~$?On\{Ž}MrxnlEJǶ>xqӉ7??x{sYSE}:~]>AG~x:sCnfU(?3=xuqj/\|yr.'=߿hO͖O+s_}(}*z|7gg?Vgzww~J6i[_ UO׻ztl_o?|yi$s5LSzMOm;ľ&E g(G׋˶ѹ֖4/C, s@ыGuvwsykեԾ8:݋|uu^HZtܿ3^__n?}~noo?^w yx:<_GWW ZjoN/8|.^~sOJWR4_~mc~]׿lYM>snX_щ>_v.oGQe}~V iѼ&6[fY|bfi 1;K\/[/!^߿zuوNH;,||8YY_|5?rһk}w}ĊᗖmCᅲ^+B9T·zr8̶`8> ^Ys|Ӧ!g|5q >~eM8Ҁ_jK|V\rTȃ;' RTb[C16)ϾGdaqtyC cW/.ꟾ\]|ݴwl)ww/5lOX"~4"%ˇ?lڧ DDQrOhauxHvl#oE[|VӪȕNEun~_6n|=Z(,A9,}e(=G7;h+Zzeߥg._c7'^$ L~;1X:hS#ZeC-;D~B V ۜv(=¤ ;rgH1Ÿ"yTSObo(c ,j?G$h+ԧPaۛw8vp=Ƒ"#)|EG'pf?Ghy%Mo/o B Zi |fD_,#C$_S]+6cwOd+8V_Hik3J*:n𘆬2֐Ζ~iOQ*.Kܫ *9G)<ЊLlqP%3GOv&{8@r"A|||%Cr0oUP4fhA6DouxУ϶P FG4lt_D#U=["!4zp(acZmq G}ĭţ!ղO#o9 ]"{(#DLb?51pI (BդQX,&}\1:=fpC5%  ]N]Aഉ nqTk5^¤1E-BԘw⧕9 9@eszg]𻐏 !S*w#7 (l.صo'\B>sP#E>0"nH::O"M&8~9X~B ⿴+\?oyw?8m8o1&p𧎆FBɿw{7?vlS!%zzB0ekƳbc@fn7':)V)o??alOR-.gHA\Cn|ͫ!|sD# `Q]+V@A1!h&"~;wi4OiґTnkͧ"-Ų-Afz}뫋?}_}vO `>g{cG84^o?Iw>?%Y\Ll|` >P6~|^iχ6h;f-kFb\7ú\y_' !l|F5,ߎDw3@I䁹6׶LECw}oa-fx4ԓi+]k3]vF=hu><=wONJR{ѾDChJdAѺ\;4YۓQgܸ[T|sge{(]AsdjK'P{μ y M9NbWQS)ia[aWh5bY: ` ńFZEa&j<-NdxǑfPbGKVl36WRP^  ́,_i+GOZ7Kxsvhȩk;# > mʳY;+Y6)A0eJR 'ȏB=D~[v2YKh1CCmot};o{~P NDG8c8ZW6}=ڶݮTG$~k0_3m+N;th I+M8rm4D;m! @ d8Oꏋg ) '9hgҀ)˃VLSZ`/(-~ڻ)7+ Cz)ES$?Z/(SB7i{eڢۉӝXolInʼn:۲w|Zyb0bNvȌ9-Y*(>1v$߁,HWfT-ܮ؂-K2Wu DSlMgKE^&Qb,Yh2)<9:ﯘ+p;]5eB&;5KЅhdxf`L`$ӍDY" h0e F M&pj~[ 5uLt6Ur\]!p+N^P, U#/K LxG8KPR!|h4z)++Yf1=850[OBC0ɴ굏pꖅvhxOZ B1 EZ7ݲ것w:^rϖ!<&|k[dncV;?߽CV.ELuI{I wSAAln Ag2HFJNS^Dz "WPCtX44VN N4YPI:  @HABr@[zuM,C M0htFҧHb*:uT"g}#˔E {z"FۊBs\ x$h޳p" JI:f:94SI;{d4LZwC/rJN{+sd!iG"5 8K+2 0MG3Vz[l.>Y3&qξ=K 7 ?_8cjDQBji-'>`ܫtL՜5ݻ5a =gOWQ}נ\\k5-1qKfm ,qμ>31?qdjma4gao[D^q#+Zg@}//W</ƶ  ܕ-Sbisk=5Apbs+ev+ƒD0 ٪6dtqZt*sSPBrTR-;r I 0V D,|UG+ o+E\n^,5 UUiFCp@a/l4 ?n+ [h[X.IԂOl̍^KCcOIX)Ä})ک.anI?QXi[j:S90ǎk?:NzrY@1 7pM7<,Fh肙 T?{5gӱs 0R4'p:tq+Nˆ n 6,` ~w0q_pCT$E2rkg^SCH6[yJRBJkT M-g%0a1u{`aY\0p(ܡ/[sH y($M  bT6;N¥u(8vUotW\|1nP@CtPL& 5X PY8:T CmؙdS+KGk4k>ZF(1fUzi6 0 rBdÓF<D94wQv,?2[ H0m 2S E6vK.f7xr.|`yuUijMu<̟~v$]h x8}+^/Hv G[is鴭-C4khܱ:Ң^2X;"/7EVF`0KbG Pݥӳ2W'*_r3?nh}NR,Pڝ+'sz ,%yjK/5T& J5ogFv;]=ȕ]XGFʅi^Cd-r 8|~պQ7Y&pYS{TeCF1"-"(CS޲g'r٠o+RFX$c؛hJ@Z#Iy} >(vTXO}o C2 ke`ZlFcF,1|UM?鮸߅7ȅM/hd*&^gЃ@]JjYJRʭ³f6 +P*~a\H9 |?w `*\8[eunA#ơz2c*/.?! .fCV'*z 6h۾؉gT(:#t$@zrZ,M!Nوz5]Sؕ j<=HEu~dACPeJdZ*gCS3^2BJf fYlǛM1&R_&QUTt0kx<(grҍvr5~Y*2w5.K02hnF,̍qΒHe-O}uqu&hD[Y6q+pH v.mb)x|j`=jwuɜ+rr+łrtjY8 (\ۮ;M΃t fඓK:u!2ZF$9257q,uvzYBD:=$S@y,CvUh1I+b wޅr8倫 |Ux!!i|f, 8Vl FkӘD"#-xIAzĄ&$ZuUSKD}lDpxqh7dp'70T^* UdĭtP,F s"gCձ{3 bn \à}|2OM,'0DŽ9Y#e6h+LBڲ <~DCe{J4&4,? rMf a`Qp%yH†;P#erd!5 o#誂,{R챡)n0] =r1 GV&(ݼ-hqm8%&,ͣ`с mZ}g i#G0TPD楺7Mi \ ^p4}4j.]E4Jx!)7pga L/-l7qGV0/&SO1(HTEs݄XcBq6,`L]L՝U1C)$ώK'ckQnEyˀv?[9Y ;-ss wT*/+4p3=㭗\-kfI@ܲFeY2D$E6c-RiņY\\Q+&UP0U 䰉Y!bGӣQqDhZl'*J뛃yofT>~(9(E$ zNҝ B+ɍN&P\^M*i5UZC$VM`̧Ce-z7^wzzw[l=inm Mq B4nP6! so)mmv;݌$x~(6~[ٸ *>ĺw?NIFiQ(Fap'm?+}Sl4uPO';QdLb8E6#EJzeFH_6.&6'囄}SC=a(jb8Vqo:nQ0 +{V3fSNO\ nw8Ioj.͙*zm6  -/hBUJu0j'mʽj7(c~HowwK>{l|oKы /CWQWzNЍH@ƀd}ע}tEWM1IuWJ+a| x$K,]ʅ< ]I ~ha:^C}@T~cUDžpBI0w̓#ݪq!'7v+daoxC.Hnĕ>0ڱyrY<=C@I* ,<9[IWu֓i{8NP1̭ҚNm6m$  Y/*#w+"E c`"c:Cbs kI/7ۣ\I -S3 m JnK 4^Tz 6Tqsa5|e"fcfІ-v5nnfB7}҂(7g~]YgVf OnjҚa4B}4Z=z}&c%fg6umMr8KW %"&o`~pXXWiU6 _njΜQ`Ί`aQ*}CAZHۑ,@^LV)FYߧ/UKrͭ.CU=j*hDdunN0ݙY@aj(L23jĥcкm\ٺ-kI7)غu{k&T pm9sq\MmQQĞvWnut: ]s8z}KCA1$0-KBۻ (k;7ރ;RI;cA4Bw OILĦ.sBW\b꘲LbVCcnA,+‰7&a=B0 nx,x7 ''6 F9 Dࠇo_W~p]c, S*KzGClŜD"^ sYm 9Swo2yS _/[.STa,Z;q٪+ h5rוHja9۝rOV1%[v0~б78j'Mu+dnHJol89[4/ ;QN *HMDDU`-iޛQ%3qwuO m ZBn[M'CtmV-y(hjQ5NAY °@(" tur5';F#361Va4`qmj^ F!-vV䖡B*BtS 7`3?sd68ᡧ_ [ GW2d.-&NT8k|Hm8؞# ̷ufFUg=0F?còfn$ |(>3m80G`:ZE /9Ʈ%W8i .[;;9VY*5kݶ YSgĽb+pkޠ3F` [d^.s{.Vr#S0B\ j@qDs4e+M-S+#W] tQC,=YX)XF%ݻtaLEПʜɬ&O9Xwqbc{l!fH K0ahb-`:u$kj &B1I#T31%&JT򞏛Y;/ܞC F+9CHL(L  ZdnggEҬͻl/^{KK"*d wwwneƅ,JTm!w t 4,VB]jN)!c9baFBFw^%(E$`A*qI|j0u4 {vg91tNa:D#&7,t8Bh/f2m/z0􍸯9cYXnH!5%FMK]6q4Tc4X&ʣ<[. Qy<O65w7p dPonF|Q+!4Y^+3jYsr (G7Ft̔ #)D,2)4̋f%y8 zv=׉4lzA8#|.}o([ZЂ-~)(K)B;~"<<HW)5oPrBnΟRAeT,E2&?鶳vZk6k&טphlaΩdL,/8pTf`TznMnEa֒Vi30G%-={Z p KDm!}O04B/EQI0mmU~~_E Yy- V%Z*<&(e սlC1w5LfI/X7݁,S_ĂQjk4Q0ƭ=[U^UZu= >z= #CDIl̲?k T1?iѣ^S0zDU0l"4%v6Fb+b(ˬAY uPȔB8leIH&ZGdQfzhi)Rpzi4ԥE nr6 A2Z WjɵD_2}G_d j& 278'#ͱ Jz^0. W8R:| ;^"! Xepa$jR yY,g! u`cw,3wY ]q_LiyA7+IWSn{{;fݔH i8dt%LKvR/0I!Y>Y%=yH*҈p6MӶ; W8pH/2J |d~Ip8u^i/ĘSۛxfZ3V9bs}\t \Nq뵣QH4̂=:![>6/B/ԢHQ)d0Dc%!yJσr3J<3}`Jwq(ׅ4yZ]ib K0 \FG~[+vE96M,ˊ3P;SwѦy ݅GTJKUX 0dd ٕ[5ZY%G/䷪pobKa8||xOy8"kOU[ъa8x>nA!7w> ޠ F20n(\ƨPm=ۊ"@B@+B0W+%OaK p bhry%Q]C/:!|+q8:Z)EK1`0n6]Ywz- (' ìy ;W5- {9#>g̞bPUO0NZl`{ $N f)LufԌBGD~MlK2MGCp;<}+y /$d.IX)_m)}ӕaA9⩔hmMoN,-`Mda(ÉrT;-qC@~)ELRo YR<lx`Xr+w  pr\se'gCB5T4,T$'L%H竮>4_[44ڝ +JڜI@'W꺹#Z).v/we=̜e28r.]o5ӃL e V84e #Wy+s2\Y;*d Ira lby+|C"oHiL'<5fmb^d8OEojR T}+W"~ qювE7)Ս:C.'ywi9r<׋>S1w0fT>>^2;&e/E i4BdeiiЀyV'F^Β,9H@M9fC@Goo.dE0Aӝ-A^uVѪټ^Z"cO ;VrlSaΦ΋tL۬HKۦMˈ|V9:K[`iQUƳ`+2q09i 6։WAdTr&lSOwF<Ԯ ͰPz͓;~l鶫@0d/tK):]{)8EsԜe <hAjX M|QvګUW쮨&Fqz(Kv *i`I/5@l,FaPFtK=UBFi0s"˸rb#*DU:31!#(hTD46ve6IK(G5" [(h8+Yk4dV/\-Acta DD i#?L5OQ?.`7N>I{TZT704/.C|Q ZKTcj6{#0Lu")"OALxT. 3϶-<&OOόZlKn7H~Յ^˓< FfTM*$F(lls퉗y'o[Tg~hPοamߔ( IQdUg;o 9vA)! [JdE:ek笲a6Tj 'y2^^7Y+/=hz^eQ@2q#VAś& B-CA!*R@9Bl9j`N`=IG75\PFܕDsh9湃9:_ܣzIs凬6PliFri K?n,p7\ 7x1އ|h@]bԦC1w%-F\*Xgq}ث*8;DS4 OoE7` ZrM v "sSZ] @0Ă3h*%sG4 NWd-lynJ_}E\XA ۳0C\cix`z)-yڲ5(]:@IiU"G=GKg(ĐGއIJD`[+kln<i=UcG rGeE!\oS!)SrsХ+2j0?@nЌ ` yw !`\&BW5W=7oDIȕC*e:G5-$@\TZop:U\:L_f.S,Y늕GjNaY*˪Rqc2:VuA[]566nR{` 6 [Ou.i01Bk,pi(T.+aJPW>IP $:$aKa~Ǜ:"4#+w)vL[YQM]CXVru 3S깓G  st= Pe<3ZF1E4\?,9hZ Q!#$uÑ+bCs1 mmj'Z;YdFNHѧR_Cn4:iyns{DƎa36sԆaܙEih>ɒ"R )wJ38TFA)(Cz;0%;W|M&2NlǡHnP&Tp^WęL}DqVz>ܽ8"%5G,"e5Ŧ$ mUv/x:Xw\fDrZ麁eg<9lSڰѺ\;4Yۓ!3cKuu*CC Y#Oh&kg* QJ-.y)`fW092@yDy0JYweQ(;ޕ "-GRj-PVjJ_=<jWRBF&0UF yJڰ;(^Bs#h4曬p:4 l2R~&7 +;J~+U,TLiϴkEnmm`b@t %ޔ{6YYϋb;/u &,zwfv?ףn4E/їTr-YbHx Xx0}Z>>ٱF# 9"PO)2E;ںA^BL)arjFJX(f4bZNquhKǯEh4Jo,LV`f  FA>4㩁IW"#̺B(Nx G:덋zPpV'Rd.AT- +p[Si0AtRRM|37\r3VhtE+$CUaF 4!<2Ss)pK|kNg`TFjezweٷI]*)Ϲ h=8Ȇ~l0ryA7팠Ql°uñ4س4YCDMiBn )Xzfid?OYMRghUϐcI*u ҜV_ry(/eB85_EIOM~|k{"MFmj93ݵ?Ư-W -B;aQ$ʔ]F%H JHwY'XY3̓ U!U=-[CWpWjiםD9 8t~< @f (}pRylOpv-5 6ţU.iݍƴa Ä R U0 8(2]O2*F2/Tmku,#3d60`dbkN#e٬{m+u2P͢^KUep;)U:iyRYĊ5nu X+l,o$eU6hS*ʬ;e`pZaN$MyW_"fht0*:ȝAo2:) ;DzLSFp!v6 NG EJ)H4K`̈ }=dԓle(Ve9aՑwpel =ƘeOK~gL^PɅlz2R(¦BDhڪlj)/`͂Nh4ե \ Dj .5Z lr _!ˑBt+F8aG6'YD;*G-n{JgU gCYl{hO̽4F::٨wCH>_VtڢPXl.n;"I{cqHݶG9cȔE0~JlM`?G,<%7u+wxzG7rХ، W[Oʭ~0&M՞FɁ.^2c7H\e[F5fOY K sGǒ oq6}s@'dIY`ZiTؙJWb2\؈D&z0Zy_dV۬l͟]yҭ2 Vab#pwKć7]'î3*84 xLo& ή*܂ů\n0Pz8Gy3qK)Z.W,AXⷨY9 tlU Lx-fm5 d2Vh|-Fj+ZEn\j!_MBw!>ůEI&Bmaf` ER뵡`k/NQ,*B V]-4.؛Ep*aȲ9|hI;#:\4w<45UY[>QH˭M:WҐ# \lU򛄩)CAta0 |N)#rǝ<< v 1Ѫ58 ySd*f6 |9[YXxh`/N q&>\QIt_TPeD"ܒk)H4Vx&M÷R Ѕ1,\&[\ ]i[Z͔6q!͜'1k[UKiDm5e6m l9MW "ٿʍP\\[`[*"gkU_`cM9DۇX5Խadə'qV^W1`?Yr'Tp,)(΃i{$ %NBuMtuX.eMDnДJ9(LH a CQ* 03J`ST͢"NpJ>ЀH_=&PAԱń=1β[2p 2H$uZ)ñ }(wL'Q;=0 V6QEVb66Sm!x' 2A#U`wvL,E, Va`Μa8ZhB_s{l4H3BK G' $1ꤎ%J6Eې%N GDq0"r6P!ͭvx)YLPg\e3 })Cy11\Qt_0PAXjA#ET,;1u`ЛFPD*W j;jZ\7h:X4 #D9-UEX2ʯa} -{G1qe< 09jD īpRD)ɐ&?:uSqAE^v4˩Ë$mT[Dq+@И_NSW̪ %%פo8?7%C3LۢֆQ" 4 3M&0WfD֩|OEZ;Z Rm k9dz!5 kI0Uڮcp bcwd./r5d'@)ŠWbhT,wίg]1v`*m9om8TN `5Wn3t 34;"T;Y5F\'׫oyUNV1E'?118?MFo*"#8#8@Cd+hk#)L))˽K2*@w\FtZv0$ rkq #,cB<ujUa `[*F_%[βaf6+NBSE&J@P%[L_LvK9AEؗ ^a%R ,,.6’b{H2GPi̤,R ~Konrf~ĉ}d?t=M뮧+MVu6z@[.yY, ҴL!'\xPymٔAe)#kS|,u˸G6"N]Za4Pޏ 6JX'Gxoˠ˛r_ErOeRj+hѝ 5&d3nctQ x&mЎ Qݱf/3K[ۮVrKfP`BStZjIKGlI8^}O^a)s(I U_]{D*FlȌ#a^_;ޕxl.$9P,L*v!UTӢ; :Q3rӠ/heuWܥ&Tz ԰O&n/7CK`;чB|\MD;u{DCr%l<}p^C‡ *'x[Ƚ ߗ6XZ,euoך}/4gnmq}f ":JU-ps(~|F+Ѿs_H`[ѾůlT-X6Р sZB4veW e/0 )S)+k/D1EEȄ;,1+2`[>We$,h|1v^7pӠWut"Ji*oHWHID2HM mGB`~$rWYMܹ-Sa6lZdq%u55U8:QzH%js( י.x5FF2W 0Cő!"!Q>+<,Ehmt\W"g蝞ҁgyj)q:zY^;JWz@/b~:ͭOh iۅ,U]lt.5 k~ƌ igy!T^T4}!؛`-nQXL¬B ? 4LAk H+Y_ܞq0 uiMN?$Šd;rJ5ZaeGY@Qc-Qfu_jZ֢^Zz&_t0x t,r[iJAVnEm+b=[*ӆ_ "+'V^1&1e(m\ 8奬v!,~гHس5 שp 5ܰtS54EfHe[!L,4p78eCg?s<?w`'[r6 5s&f S eǞm7' %-fAZРԹNTQ^I.C0qFыZX:lww=M+%ZjicY{"]0BFENGPEFbGxT"LB$ЅַLlȍi_'iSW7{$xm.;a; NtDCe1fMM&8hKH? AԛiuL'wy 4X1o& v[? 2kASYk=N0P- u} H`~+ DXʎ$YVSR"RWrt 힪*N.m#cכeIx76TFp}׊fvҝDM^A}HȨX5 P͔EDy_R8-(:=4SflV*$B Gx#tqT.OE'O-:ƌōvM3n31eiA\~k4],YSKua0+u j\S$t}luQ2S odX< |f %b(ォxTtbu+W FlOH E <;x& ~7Jl,F ؏4kKSBZL{G 605ZWZ}_^uT0`jm^J;'DR. ~^[ bԨTq9D3MTI:,75"DE 8].t-CLTtxFCP4)p9ڱ'GnJo0fX\r%~Y_ ƻ]}`R7Zף4e-ZYES1v Q h+wfEy;űȵ(4Zţdie%z讫jBߥq#P)Ib뚟)+G-mRݍ4W({%6Cf#gK޼$6@,Z=h3! \UWBR G˛>,Fu{G3 p+ʠ/c|_ -ay.c{֛dU7(ǦױmUFzN] G 1]mPO4LA ƏYy^PnuQbn8TW=kYA{:r;v~&tzdJ(wP/meVE;Ȭ}QŽqK""ZdI}ʰB =~ V\UbATn+k( 8Y=hKH MS3ߥy6wz69nJfk l8@X) Nfe?L=i^l݋Ќ0+ S9bh )v(:ײn7F "Np.:=3 VYJΌXzd +&a&x> $(JfYfebh0#VVp& "q9=$ȼiT=*Ay p5(^SEl| sL=4Zf5i\MOWa' +s!vm <5uM9.(jE2Rm1_tcR]l@<8?>;;za68I"쀮 5U[{gl6Ƴb%i%2?~==/[RLCq6,< fꢷlf3㡹'utz^2MQgЯ 4FG~[Ѳ+:&%бi|p/$S[]f9\lڬ-qbT(,@zπ:N8o91}y7 #Ul|g]lje],Sp;Aq jat.]Ӛ&ģE.`#ټ$[DoD4Ş6$^Yw'R;㠍 ę, df)Reloq Ѡ#ov`]ZřF\| R:7EC"7QLG!esW3F8D*B652.]Zɐ<2':x~ߓTL`9q1 e?p6Fi# ٹyG,l6Xl`{ظh9qY3"{tQWFX(IG%oʅoW?db'Pvԡ'@E6r2!b&ѝIlEf6 -dj^[(b`"ڃnP, JeҬ'>e+T0c:.TӛbޅYu,xʈ?F*C\"F,(}7e] ɖ:\ƺ]:ҫVZgm/LR{S}9἟ؙo"WNUFzLyLU]Q֣~mBۻx>"#]D"ljrIs3(ͺ`?5* *c8UaM2go`0de()27eaM㷶 OG>99ix &3p_MK%A5XKu]ɍ¸dDٌC$ F.zq\$]}ǹ{q(+{1dXHhtvaS!>=TrV!1PI- (RRqBoY`zC(@|jfNr2qܙ;ed{P#/z+G! ӭ}k"J<ݡ~pH<~ݰPU`"❙2 pE+ ϊdQe%U@\-|? WYRdV%r.<~ʊ -:_D-ie"f>FÄѨˇGY&[J$Z۴i=7\L3L*x+;ًȠQ|>kk!IzIr9ת &e)Hk an vR>µB-U׹LhbiN*<)~TQO-f Ǝ=d#]/X2 O+b‚Z] 6lZ z܀r $e(XGT{YĺG;lYɐ͉7F=E23Bl ü!r.,`@< dC E ԢlA܀BiLɂp.<تN2jGƫEY_ڨMt25&Qk G`N)8[T1͊Lb6 By=a [k_bgV6JPzY42h0?FDNKHPnSkJ`1!~_7tCPyQNg%o,l~tE bW@0 zIX^s"2\a}K׫&0ͣRѵ߁G>l96esE oAUϣ Wa0DD?B҅MϝyFeZ7s-O\ INVc[I3Smk46ݪDȧeȠbiuj(eFIU.|M椫c oor`:zAVɔ=蜳F>a@t)qn8[V;ޘBץWeUq 0 VVVbǁ4LÃ^8${Ӿ;@[6o'*#]M֚ѲU!b2baOߥ<\ {C$ 屪j8Xt|"EͲ:Z.ܢG 79sEM&*돎?D#_@N~L7hrP `L%,n"7,%@y{9@3JNY[V1)?tѠ2ՁoX-y7n=A\8̰€9^_S~"VzW tdmY00 =rBzڤF^;n<!?/ܿ??:Y9~%~U Q6/,deCG"5sWaPKbtѨbX`{~b}MqU-ujF:vXS* UE7%;65,!b#/Z;`_ YEbrXbQ4և kݐ8 8P_muWlF_:sI(ߊ!$%^tY͆sV'Aj]#mGVpy1YiUŲv1 eL>]WS;C$颁$h%[%zčKR`/wi>FZ T!7 l,t]ɋJ9Cr6Er^rI<.'8Y&=f߱= ^˖uY%DKYoQ^*fi|P)7gAH.x%$-1٢[T8`͑9{<)`l|z%r{nShNr budg\1Z1 y:c YE¸** Grf/jňO>l*4"BЪ8K POqwhL_v-p{Yz}uWz],Ǧ(11l~zZ p~w|z$yHʸ~l9;574rG6Mdb-dFvDzJi-]!m~+(S:L R6bߤp LXVsB ]:r9t g_.LanoJM=rIŖsm8y0 %*hpvfeQe5yc}sSQN"TmmۗjXZP ܱ Q4 [vڃȘ8񒿉m٠o$yWHSkq|7;)ZJmUK RkD` bBCXgC7IVYD6OaiN7cۈY#Ԅ~D.mo$ } 4"`VVq֫І'nҮr0,F?g#9K"B IsIq޸Oyf%`xZa%_fq UQ ЊhAƩl.J`(lB*l6`Z˦ly8ol@!vT덊-wKH쟈mrHw5֔|h*n-hv4X%p{jŹfPZ/KISD|8M$-39=+7ʠ\ԗ]Ve Wax"Y~Y Nmm4,%{{K[krxDxB f ˓Y(#L)Z6?O|rmE&$LbG=G ±^ܹԀNNfѠh0I\r0g)+6`Z_eSn8Z۾McKSWhO.j!IEfv;]Gq̬mrn޿H"r4 NpL,K뼅8F^ZRu}/ rWJ.K15au}3nmHY=%!cpy`҉ pmely~cStf{! 0+q$]D;B]m{^Bch3żӜ&/ڸJ3d*ֵ<4^q]I[Uv,[L7,b; Y &O9vLl?WKY JaaJD=M exz0x(9ĪuH5Ģ܋(2crqMM/,ޠI2l .Iں^-%~ C ,2:E0\JKFmKӐa`ObsqδP5!Vh))11X*X}*0%uS7quj|[1 (*-{`|T@] bUO1֙NH=(WRցQfޤБ_ bp~o]) CtlX] J0OOI3bB^R"O5ҍ_sR'Hw(Hq[7‹y(*8B;TH/A"BV#G}xتDʱu 0SC!sR[a:xrN~{\0Fe<᪟0YBd(Rlz(WV iH*0ᘬe6‡ F؋zgϒ;Pb*υr,)kZ4JIa l1XXa8ڛF(v H<lLoӲ=MD*8\& /dC%`dY3Ps`Oó+$1/W)4 ;8Xxip(T|+2S6/; U$^OLce<;yB9ZC HA-BF\mjp#7 J*`9 >F`^i.Ǧ9X0p}&O^jp\M*N5xIT #κAA(w#սy92ݷclƠl1s6P\JOjZ(A~}(hC-6lNYR@,d#DC垞ĕ(eőb nR|Uk*֒-l?&Om8ž]Re<6}G 3?J/f_a0v5ڧ’J/E*kE$ܑX0c __LL 席L"4q&!Ja&GWj!&v33<`#F_F+@z+ tX Q <˃"H''4*5Gm]t+q!hQR40& ]TrQ|dITLh S|n4XoIPbuD[-H+!aED(4! Q7̫HhTg-iQēldqD l WEjq5KmAJ@UE 5:9Q`IyoHԂƑ>;@;aSCWNdt:3]ZzڟCc$"~?-͝8}n ۵nv? c^c1ɋ!L 2VgD0A )%kpeu(jt٢| bˬ&rI!Yj+ 9|89&| dalYי(Jbr | t :JJ9([A?K4J[Q5EWjD"Uo ʨM̷o HXFZ[z|( (9W @,#Shdc#p4g} YwLr%*([S 釸mcb&Hѕ=]ɹHnt-h.:Gy"+&[dMSᨓ,|E dۖhxkeI~ȟ%Dqr@l`,Dxn.ɰli BMFX!zEA*yܟ 0w䥊L2b > leN`uKSU|66[;rpD,bᇞ"/ 1 H+%~2 >' '^ GPZ$YaQjb;PBi+!P:jezdɾK}< .e_<?[9Y\k; Axe0{ \J,&(*0L/ ~[RrI|'jm2dUj gɨ ~O 0FbN1ˁ<"תiv*Vd.w҆8 %/}5#c LBB12[]Q8G.m#|;ER&@;۔вk_(趨M]9gm CaZ;LMvžYC0:G(46"’kW9uIї;Ko&..)jls(ǬNNeN1};Var<Sf zqEMl d4궗(3Y-#,'w̚J*$䪃fTy꺾㓒SQQ{b ɭ+m᠘Izljsv[ :VN/h;nfYZgEĆbƪ8;&^է]F?nN/\hm_9=;x@# 81\( !/p2-&W'9Gta iQ5*$1r0 u'pIIXfaq_sƲұz"m3nRS!Pf&` iZ6X+bRYH"4xEYA?L֝8--K@ꊼC/jù6XkS\6EեꁸO%۶Oh*CX@(Ę#FL=҇gFtq<7kU񋒕ZY0G|5F݊ RY46-$Cuۄ[GgFo*=2ς˜ Qڃg [>^YÉ]̶iAP)Ƭ v[)ŽEyґ{NQf?ז:>YkOo UagD<őaZ@U]1sj,L5 RtÛuh,kۻ͏zT}̈GAQV P9r֭#PdcGRUɤ| eeT$S] چ[/HpL9LG- x'a[$290AWPގb,Q6El.ĕ$_ ~JlE4*Y쬪]&9 ݿp! }Ӑ+b3Ց7=iRb ɤ;Մ^5Jzկ4Gwrr+$|!Indr`@.T!;"iN9 )PCp@"sc+!0)8IR+%9.n#5]nx=yNyweqnpDzUYܶ*z~sߘ})jqͼ$^^8Ss&Se ZDZy4ziu|/*.B 9B.iQhqmt_Nd&\^9I-^㇐VB3:._lbgp(#WLΔZj,Wܳ́gc@^cB78dRQ;JxUA!J!\2tpfHf fBZ5RQH i'QS`kW"}qL<ͩekda}tm8dS4{C"В1QcMQ]7 z:snE(o@)%A++ 4v *̞+b<Nuf_A+M|<Њl$r@36g1' 1$9#.)BH-ZKsŽG%mwlQJ |Rرnct%:{87OǾ]SK{ZX@rN\[z[,+a]'ru` K y(Ňr_Q.X@.Iѡ[u,{["QAObMf*@},ucj  슣*o$y~l{8&Q\-Y *&S>]Ka%JKBHxs'td;,bD܀dU%;bj2ge֏)RX;ߋbm[Dn{Ycr.I# ϑHLNlwDm*uA~ Eobz)4|aCs1$}ʻ %2'p^42^=;_:anܕFi8AYe^Z+:OI;V|I围]flyYM !b ċ e{YVϪX窌xqroN u)+]\NY=`ĨAXv)U\a &, wsT$oEHZ_aEs, W¯֊U ׭=" ޲&+ް{Nؗ c.p̙GU$iW9m8`AWE&qԎK{~&Dmø,9 +m`(BQ}cZ=K WZƛJqy#ϿUZIxGp̬0(+jH'aOmΎ_Yj_~mog7hQ{(~;[üܡۆm /DD_gϏ7_~E6/ῡ.Q׭Si3,ҥccx?v?#^7'ʃ> Vr|ҵ4[ 'O]`]eyاE*Zy>K2mQ~zz\{/jY%8)`(#-R<Ke\&tfq bs/HO7;盏)\莓{?{B'x|a-CF[,Lb[%#U+8qTMUpXN]=x֧<Bw¿޲ ޼'o dDHze բ)&s޻9"kP&Yol*ea?عUSw>NȚsQzJE Wa~JHP6&֧4 pOŀ%FsQFFm_qo&"؃~n.ZRID)@@x$ipq$7/?:}w] {opTRmA+Eת-Yp l}?ƪuBHðSH/fJkY"lǹ,0La0_T.8զGl f,D駟_>Ǐ<5Nq8^I8 B ܬ tSr!i=xC #W oAP-&O:ܝ[KP]Y?@Wvko]ϋRgIx>NR<ˍKlJ5ǿe 7D$12&I`G/'6[ ?}T_GЫmrϛڲ%FKi|b_4ͨ; n+e'ޞ['3m9q⠈;zT^.MXt;?WU->8\qː^;2l`  +7Y8Ϣij{ݗ/Zb<VmAsטH;*ޒ:EAS~UpFоe3ܥeS3~7 JZ-n[M&MxiMי/'qa#N_(bn?C>ݾt+p oѓ"|4/JeqYF=#W=Yݤʆ+46np WuLjgQltc۬u1DJakrgbGqzRtbޚ1ӧ_pnZE0k]#lZgߏ:??Ja HKL Z_~)+0{zwICAU"!A5D+Pu1ɬ8a̹cS[@tĚw0k@EG56ZYQH:7ڛbh[e%Wh5, cDg^Agp m,?z~5F Pqoc E~0=y|Xea=fۻ,L=իdR ,Jniǡ#٤)^d ~|R]Z(|=+s* [j)8P4m^fm@DT[li ^p1.U?|9o# ;jRyqٞe 𥷙Eq-v;184+ Ad]:z^NH2ڙyLJGށs/82 NEBPئ/JmS$Y|SbaѤ~[zate6>H9YU981%ܜf2㢾'HC=.oZ @0% n>ۉ{֋S/Oc߅l(>)|^v`x)$dYLRez!N_:0gqӜJQa";"I䋌7*79-͐ `6M4=樜!60EKg'q+{)=0T$NU9fyN& [P%UTΪ̘iZ8r5b $w"QQ MQ)D7w-PđG1|}{L ~|*[K}ҳ-5!)W2kz jǡN9Zg 4~ lB4IS7$p]|jHFҔpn44A(%vC/ո4nodY}SYN(;7 mgXkWDTj$xk!zAj35À !6(v<0&<쉠FJRxZK5*;`ڸ+,).x{}T^'\ aIu.8X5us!k;K 3<uL RH;'Jsgr︪V߭{rEe]YySTWE\2ŀr];ow*]rw* +X/A`6<#Ǵp8·#=CK &G@CL?9nAGC*ѓj]ɜ:Jt]Xf8<[|6<3_߳/_F*2)li>~ߥ&]5W'y]\b ځaz{K:8Of~ۡ鼗qj 2Հfpzy9Ӱ NYRe s ݳhe4r]yҧG go[7VtwmZ/*]*hMƢ'hrb3g)PΙ9 yR QJ E/B/þ@p$0d1w坩A`"$1.g STEpvJ3 1$= aFeҤƦȄZDe j3m\֗]I;ksl1]+"#3f j2` gRdLKymc¸E>b wHBQBbb}J;|*=h9nGV(#f> {S"V%GnPӕ}Q!)^j_x髉)`\.Oj}y{r;u#]Br#Kir<DBG=JiS6 x$MjQgU{Ѽ6 {8V67q懕-^3;{e  ^4B )T0T2)sR\ϿJG-nXI ,g eG1BM߶=HAH7w%6b-R.;@x%(84ϦALJ-Ct]&ay}2lW o֔$.m sCX99\ewi f* pډ|+$uM7yɨ vÃH2n( |qL!WZnNQJ9;( j,wHY#.ڏ}#$n)v#91݁aW!o$%v$"DKa؁4AΣ8"=RWQ貼6;GcK61DaD9^-/, oy)^]хۀXiAbLlEuaPYq$i'Gk-ܜV^e0!">,2K(|\cЌhIKö%fPIUeF9idTH_먏.;VpIwA .ӊcRVtieCѶXPGZvMwI<1p,OI'eo?Y}>\ | }>{~W\^/J\e,P\ S8 ~#7@ *!z>.XxUdVaZ^ZWYq"eqT$۷~)~?? R?,,hY4Dr%16DnЮH<Lگ`X`# l⏙>5TVN45PcEZ2 N3h.d"vuHYvy["t]$hV;NYֳx] (%O0U/;š:JuLov{pLdhNm0>RMG#LRONU3!lkj?(zvyenGm3CO*h[/M^;`A uX ֓qvlNxLs\rIP1{ il<&4Wm! >?>TY6ӷgwfhK-}G$>hD9}SWQΤå IP똪rH#@ p 80ⰝGǑ)*i1|]VRvaKPe#\V]d ;N);ď/P"*(nzC\$nحmd_@?iw]Z yoFhj#7X-& x.!ٴ-ׁA4~5H6D'w#(?l(r?wqGmfr(4µ(.|$}#h|ݜG"c|]k&WAqEb([ǰ0A_.e.¤7!Z$e`A.i2P"`or'9q=@氪M'OO}brٴw롺8  M>{4Qi#!Er ꮀϺ,v@S5| CkٮݗjW;iY\:-R$aBO,d}\C |Cvq.{&#j.U3NɗO{lɻ( 5NپJQ.Ncv?P߲&nA Z t*#&,0#?kY:EqZǕ`q05HHъdzKGhC_8 H}yxv3{.,]` {hXp}C̨=: {GS8Ȥ1\x~5~)}5;Z9*42=_ᢳ#}a>_Œ^GƗC]W;=uE~̎?+Wߵ(Iwi/]l%ʕؑPƮ) ~Qϲ&![ ME 'v39W2X%yQWT۬1ݮ(ѽ>8bgwOQ#=|cpKz_ڵl&s11Bmoηi1[%~@qOMzk^U-;-Φ3Icj.kc}Qkfi$'angd*tj"f|i&zAwʞ-4Youg!!ENv69wuk jƏ7"iL=ZZ3ۼє!7vp3?X23xeń`<, C]Ci8_X ƹ )B4Itx} &6MHtxDz~?{rU/r%3Z_zatw9)ϥ~7s ul*HfYϝl <,(y޽u:"=R$[@'! BF`a"s`19?vx LՖjffn' qx*xUY^S7T+Smo@P!: (Mm#{|f.ZDNA^< W#h0K5 s CV9)LFq$X֣[*gD ky*8_` !ߋ"þZ|G6đ5F_& Bestellen Sie Crestor (Rosuvastatin) 10 mg ohne Rezept zum niedrigen Preis | Eurorxdrugs
Umfassende pharmazeutische Kaufberatung Über 5 Jahre Erfahrung! Versandkostenfrei ab 200 €! Schnelle, zuverlässige Lieferung!

X

Search

* For illustration purpose only

Crestor (Rosuvastatin) 10 mg

from

91.00448.00

Commercial Name: Crestor
Active Ingredient: Rosuvastatin
Production form: Pills
Utilization: Treats high cholesterol and atherosclerosis, it is a drug from the class of statins
Available Dosage: 10mg
Lieferinformationen

*Preise in der Liste gelten nicht für die Schweiz, Schweden und Dänemark. Kunden wird empfohlen, eine Bestellung aufzugeben, und unser Team wird sich mit aktualisierten Preisen bei Ihnen melden.

Last purchase 31 minutes ago. There are 36 users looking at this product right now.

Free shipping for orders more than €200

Discreet packaging. Secure and confidential

100% moneyback guarantee

No prescription required

Beschreibung

Common use
        Crestor is a cholesterol-lowering medication which used to lower cholesterol levels when diet and exercise alone have failed to work.
Dosage and direction
        Take this medication with or without food, at any time once a day. Swallow each tablet whole with a drink of water/milk. Commonly dose of Crestor is 5 to 40 mg. Dosage of 40 mg is using for patients not reaching LDL-C goal with 20 mg. Hyperlipidemia, mixed dyslipidemia, hypertriglyceridemia, and atherosclerosis: Starting dose 10 mg. Crestor 20 mg is a starting dose for patients with LDL-C >190 mg/dL and aggressive lipid targets. HoFH: Starting dose is 20 mg. This drug is only a small part of a whole program of treatment that also includes diet, exercise, and weight control. Follow your diet, medication, and exercise routines very carefully. Note: this instruction presented here just for review. It's very necessary to consult with your doctor before using. It helps you to get the best results.
Precautions
        Do not take if you have any liver problems or have ever had a disease which affected your liver; if you have any kidney problems; if you have been told that you have a condition affecting your muscles called myopathy; if you are taking the immunosuppressive drug, cyclosporin; if you are pregnant or if there is a possibility that you may become pregnant; if you are breast-feeding. Consult with your doctor if you are taking any other medicines, including those which you may have bought over the counter. In particular tell your doctor if you are taking any of the following: gemfibrozil, cyclosporin, warfarin, antacids, erythromycin or an oral contraceptive.
 
Contraindications
        Crestor is contraindicated in patients: - with hypersensitivity to rosuvastatin or to any of the excipients; - with active liver disease; - with severe renal impairment; - with myopathy; - receiving concomitant ciclosporin; - during pregnancy and lactation and in women of childbearing potential not using appropriate contraceptive measures; The 40 mg dose is contraindicated in patients with pre-disposing factors for myopathy/rhabdomyolysis. Such factors include: − moderate renal impairment; − hypothyroidism; − personal or family history of hereditary muscular disorders; − previous history of muscular toxicity with another HMG-CoA reductase inhibitor or fibrate; − alcohol abuse; − situations where an increase in plasma levels may occur; − Asian patients; − concomitant use of fibrates.
 
Possible side effect
        They may include all types of an allergic reaction. Also, the most possible side effects include muscle pain, tenderness, or weakness with fever or flu symptoms and dark coloured urine; urinating more or less than usual, or not at all; nausea, stomach pain, low fever, loss of appetite, dark urine, clay-coloured stools, jaundice (yellowing of the skin or eyes); chest pain; or swelling in your hands or feet. Less serious include: weakness, dizziness; mild nausea, constipation, diarrhoea; sore throat, runny or stuffy nose; memory loss; headache; or pain or burning when you urinate. If you experience one of them stop using Crestor and tell your doctor as soon as possible. Also, consult with your doctor about any side effect that seems unusual.
Drug interaction
        Do not take this medicine with any of the following medications: herbal medicines like red yeast rice or other medicines for high cholesterol This medicine may also interact with the following medications: alcohol, antacids containing aluminium hydroxide or magnesium hydroxide, cyclosporine, niacin, warfarin. Also, note that the interaction between two medications does not always mean that you must stop taking one of them. As usual, it affects the effect of drugs, so consult with your doctor about how its interactions are being managed or should be managed.
Missed dose
        If you forgot to take your dose in time, please do it as soon as you remember. But do not take if it is too late or almost time for your next dose. Do not increase your recommended dose. Take your usual dose next day in the same regularly time.
Overdose
        The symptoms of a Crestor overdose are not known well. Most possible of them include liver damage, kidney failure, pancreatitis, yellow skin (jaundice), serious breakdown of muscle (known as rhabdomyolysis). If you experience one of them call your doctor immediately.
Storage
        Store at room temperature between 59-77 degrees F (15-25 degrees C) away from light and moisture, kids and pets. Do not use after expiration term.

Verfassen Sie Ihren Erfahrungsbericht

Die veröffentlichten Beschreibungen der Arzneimittel können eine individuelle Beratung durch den Arzt oder Apotheker nicht ersetzen. Suchen Sie bei gesundheitlichen Problemen immer einen Arzt oder Apotheker auf. Die Website lehnt jede Haftung für die Folgen der Selbstmedikation ab.